Logo
Immuron investor hub

Immuron partnering with Walter Reid Army Institute of Research to test Travelan against Shigella, ETEC, Vibrio cholerae and Campylobacter jejuni isolates (2020, WRAIR's Investigator's Dispatch)


0

likes

0

questions

0

company answers

Ask a question


Your question will be visible to everyone.

Investor Q&As

Start the conversation

Ask Immuron a question about this update.